Blaze Bioscience Garners $5,000,000 Series A Funding

  • Feed Type
  • Date
    6/11/2012
  • Company Name
    Blaze Bioscience
  • Mailing Address
    P.O. Box 61323 Seattle, WA 98141
  • Company Description
    For years, surgeons have been searching for better intraoperative tools to more effectively treat cancer. When removing tumors, the ability to precisely identify them is of paramount importance. If too little tissue is removed, cancer cells are left behind to grow and spread. If too much tissue is removed, the patient may experience significant disabilities and reduced quality of life.
  • Website
    http://www.blazebioscience.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The new funds will be used to further advance the company’s Tumor Paint technology, which was originated in and licensed from the laboratory of one of Blaze Bioscience’s founders, Dr. Jim Olson of the Fred Hutchinson Cancer Research Center.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.